BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3838353)

  • 1. Postirradiation soft tissue sarcoma occurring in breast cancer patients: report of seven cases and results of combination chemotherapy.
    Kuten A; Sapir D; Cohen Y; Haim N; Borovik R; Robinson E
    J Surg Oncol; 1985 Mar; 28(3):168-71. PubMed ID: 3838353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
    J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.
    Bui NB; Chauvergne J; Hocke C; Durand M; Brunet R; Coindre JM
    Cancer Chemother Pharmacol; 1985; 15(1):82-5. PubMed ID: 3891123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternatives to CYVADIC combination therapy of soft tissue sarcomas.
    Hartlapp JH; Münch HJ; Illiger HJ; Wolter H; Jensen JC
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S20-2. PubMed ID: 3815715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant chemotherapy of soft tissue sarcoma].
    Shinohara N; Yokoyama K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):198-204. PubMed ID: 2301950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatives to CYVADIC-combination therapy of soft tissue sarcomas.
    Hartlapp JH; Münch HJ; Illiger HJ; Wolter H; Jensen JC
    Klin Wochenschr; 1985 Nov; 63(22):1160-2. PubMed ID: 3841170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA
    Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
    Hempling RE; Piver MS; Baker TR
    Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary chemotherapy in soft tissue sarcomas considered inoperable].
    Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J
    Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
    Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxicity of the CYVADIC modification in patients with soft tissue sarcomas or malignant mesotheliomas].
    Sauer H; Kremer G; Wilmanns W
    Onkologie; 1987 Oct; 10(5):294-300. PubMed ID: 3317170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy].
    Matsumoto S; Kawaguchi N; Manabe J; Matsushita Y; Tanizawa T
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1571-4. PubMed ID: 12355942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for soft tissue sarcoma.
    Greenall MJ; Magill GB; DeCosse JJ; Brennan MF
    Surg Gynecol Obstet; 1986 Feb; 162(2):193-8. PubMed ID: 3511556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomas.
    Karakousis CP; Rao U; Park HC
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):33-6. PubMed ID: 7200893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
    Bui B; Chauvergne J; Durand M; Brunet R
    Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas.
    Pfeffer MR; Sulkes A; Biran S
    Isr J Med Sci; 1988; 24(9-10):599-603. PubMed ID: 3204008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating combination chemotherapy of advanced soft tissue sarcomas in adults.
    Lopez M; Di Lauro L; Papaldo P; Perno CF
    Am J Clin Oncol; 1984 Oct; 7(5):539-42. PubMed ID: 6548868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical treatment of soft-tissue sarcomas in adults].
    Lucas P; Spielmann M
    Bull Cancer; 1985; 72(3):183-201. PubMed ID: 3907733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Santoro A; Tursz T; Mouridsen H; Verweij J; Steward W; Somers R; Buesa J; Casali P; Spooner D; Rankin E
    J Clin Oncol; 1995 Jul; 13(7):1537-45. PubMed ID: 7602342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative loco-regional treatment of soft tissue sarcoma in adults after induction chemotherapy].
    Marée D; Hocke C; Bui NB; Coindre JM; Tramond P; Avril A; Mage P; Chauvergne J; Richaud P
    Presse Med; 1985 May; 14(19):1069-72. PubMed ID: 3158961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.